Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Liver Cirrhosis

  Free Subscription


13.05.2019

1 BMC Gastroenterol
1 Gastroenterology
1 Hepatology
6 J Gastroenterol Hepatol
1 Lancet
1 PLoS One
2 Transplant Proc
1 Z Gastroenterol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Gastroenterol

  1. HSU WF, Lai HC, Su WP, Lin CH, et al
    Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agents.
    BMC Gastroenterol. 2019;19:63.
    PubMed     Text format     Abstract available


    Gastroenterology

  2. CASTERA L, Friedrich-Rust M, Loomba R
    Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2019;156:1264-1281.
    PubMed     Text format     Abstract available


    Hepatology

  3. TAPPER EB, Hao S, Lin M, Mafi JN, et al
    The Quality and Outcomes of Care Provided to Patients with Cirrhosis by Advanced Practice Providers.
    Hepatology. 2019 May 7. doi: 10.1002/hep.30695.
    PubMed     Text format     Abstract available


    J Gastroenterol Hepatol

  4. LIU T, Xu L, Wang C, Chen K, et al
    Shikonin alleviates hepatic fibrosis and autophagy via inhibition of TGF-beta1/Smads pathway.
    J Gastroenterol Hepatol. 2018 Jun 4. doi: 10.1111/jgh.14299.
    PubMed     Text format     Abstract available

  5. CHOW JC, Wong GL, Chan AW, Shu SS, et al
    Repeating measurements by transient elastography in non-alcoholic fatty liver disease patients with high liver stiffness.
    J Gastroenterol Hepatol. 2019;34:241-248.
    PubMed     Text format     Abstract available

  6. ISHIKAWA T, Sasaki R, Nishimura T, Matsuda T, et al
    Liver stiffness measured by transient elastography as predictor of prognoses following portosystemic shunt occlusion.
    J Gastroenterol Hepatol. 2019;34:215-223.
    PubMed     Text format     Abstract available

  7. ITO T, Ishigami M, Ishizu Y, Kuzuya T, et al
    Utility and limitations of noninvasive fibrosis markers for predicting prognosis in biopsy-proven Japanese non-alcoholic fatty liver disease patients.
    J Gastroenterol Hepatol. 2019;34:207-214.
    PubMed     Text format     Abstract available

  8. HOWELL J, Pedrana A, Cowie BC, Doyle J, et al
    Aiming for the elimination of viral hepatitis in Australia, New Zealand, and the Pacific Islands and Territories: Where are we now and barriers to meeting World Health Organization targets by 2030.
    J Gastroenterol Hepatol. 2019;34:40-48.
    PubMed     Text format     Abstract available

  9. SEMMLER G, Simbrunner B, Scheiner B, Schwabl P, et al
    Impact of farnesoid X receptor SNPs on hepatic decompensation and mortality in cirrhotic patients with portal hypertension.
    J Gastroenterol Hepatol. 2019 May 6. doi: 10.1111/jgh.14700.
    PubMed     Text format     Abstract available


    Lancet

  10. CARRAT F, Fontaine H, Dorival C, Simony M, et al
    Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.
    Lancet. 2019 Feb 11. pii: S0140-6736(18)32111.
    PubMed     Text format     Abstract available


    PLoS One

  11. BILLA O, Chalouni M, Salmon D, Poizot-Martin I, et al
    Factors associated with non-AIDS-defining cancers and non HCV-liver related cancers in HIV/HCV-coinfected patients- ANRS-CO13 HEPAVIH cohort.
    PLoS One. 2018;13:e0208657.
    PubMed     Text format     Abstract available


    Transplant Proc

  12. JENG KS, Huang CC, Lin CC, Lin CK, et al
    Liver Transplantation After Downstagings of Ruptured Advanced Hepatocellular Carcinoma in Cirrhotic Liver: Is It Advisable? A Case Report.
    Transplant Proc. 2019 May 2. pii: S0041-1345(18)31336.
    PubMed     Text format     Abstract available

  13. SOTIROPOULOS GC, Machairas N, Fouzas I, Vernadakis S, et al
    Prediction of Microvascular Tumor Invasion in Liver Transplant Candidates With Hepatocellular Carcinoma: A Feasible Concept or a Misleading Illusion?
    Transplant Proc. 2019;51:421-423.
    PubMed     Text format     Abstract available


    Z Gastroenterol

  14. GERBES AL, Labenz J, Appenrodt B, Dollinger M, et al
    [Updated S2k-Guideline "Complications of liver cirrhosis". German Society of Gastroenterology (DGVS)].
    Z Gastroenterol. 2019 May 6. doi: 10.1055/a-0873-4658.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Cirrhosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: